CLDX icon

Celldex Therapeutics
CLDX

Overview Fund Activity

141 hedge funds and large institutions have $348M invested in Celldex Therapeutics in 2016 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 46 increasing their positions, 51 reducing their positions, and 20 closing their positions.

Holders
141
Holders Change
-4
Holders Change %
-2.76%
% of All Funds
3.77%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
18
Increased
46
Reduced
51
Closed
20
Calls
$3.23M
Puts
$3.12M
Net Calls
+$107K
Net Calls Change
-$186K

Top Buyers

1
CWAM
1
Columbia Wanger Asset Management
Illinois
$23.1M
2
BIM
2
Bogle Investment Management
Massachusetts
$8.44M
3
Deutsche Bank
3
Deutsche Bank
Germany
$13.4M
4
PP
4
PDT Partners
New York
$2.18M
5
Vanguard Group
5
Vanguard Group
Pennsylvania
$31.9M

Top Sellers

1
State Street
1
State Street
Massachusetts
$21.8M
2
Franklin Resources
2
Franklin Resources
California
$27.7M
3
First Trust Advisors
3
First Trust Advisors
Illinois
$0
4
Millennium Management
4
Millennium Management
New York
$961K
5
Fidelity Investments
5
Fidelity Investments
Massachusetts
$60.9M
Name Holding Trade Value Shares
Change 		Shares
Change %
TC
151
TFS Capital
Pennsylvania
– -$45K -789 Closed
CI
152
Cowen Inc
New York
– -$39K -683 Closed
QT
153
Quantbot Technologies
New York
– -$25K -441 Closed
Parallax Volatility Advisers
154
Parallax Volatility Advisers
California
– -$14K -250 Closed
Nisa Investment Advisors
155
Nisa Investment Advisors
Missouri
– -$5K -80 Closed
Northwestern Mutual Wealth Management
156
Northwestern Mutual Wealth Management
Wisconsin
– -$2K -27 Closed
BJ
157
BlackRock Japan
Japan
– -$1K -16 Closed
HNB
158
Huntington National Bank
Ohio
– -$6K -13 Closed
3 4 5 6
7